Skip to main content

Public Pharma: A Remedy for Drug Shortages

Alan Rossi Silva[1], Jan Wintgens[2]

Conversations on Health Policy 2024: Year- end Reflections

By Prof. T. Sundararaman

Op-Ed: A great genetic plundering can be legitimized at COP16

Without strong safeguards, the multilateral mechanism for digital sequence information co

Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug

The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma

29 years without Jonas Salk: against the normalization of the absurd

Nearly three decades after Jonas Salk’s passing, hi